{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:31:49Z","timestamp":1770823909140,"version":"3.50.1"},"reference-count":32,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2001,3,1]]},"abstract":"<jats:p> PURPOSE: Mammograms and breast examinations are established methods for early breast cancer detection. Routine mammography screening reduces breast cancer mortality among women ages \u2265 50 years, but additional screening methods are needed. We and others have found high levels of carcinoembryonic antigen (CEA) and prostate-specific antigen (PSA) in nipple aspirate fluids (NAFs), but the usefulness for these bio-markers for early breast cancer detection is unknown. <\/jats:p><jats:p> PATIENTS AND METHODS: NAFs from one or both breasts of 388 women were analyzed for CEA, PSA, and albumin levels. The study included 44 women with newly diagnosed invasive breast cancers, 67 women with proliferative breast lesions (ductal and lobular carcinoma in situ and atypical ductal hyperplasia), and 277 controls without these breast lesions. Analyses were conducted using the log<jats:sub>10<\/jats:sub>-transformed CEA and PSA levels to normalize the distributions of these tumor markers. <\/jats:p><jats:p> RESULTS: Nipple fluid CEAs are significantly higher for cancerous breasts than tumor-free breasts (median 1,830 and 1,400 ng\/mL, respectively; P &lt; .01). However, at 90% specificity of the assay (CEA = 11,750 ng\/mL), the corresponding sensitivity for cancer detection is 32%. CEA levels are not significantly different for breasts with proliferative lesions compared with tumor-free breasts. Nipple fluid PSAs do not differ by tumor status. Analyses of NAF albumin-standardized CEAs and PSAs yield similar results. Nipple fluid CEA and PSA titers are correlated in the affected and unaffected breast of women with unilateral lesions. <\/jats:p><jats:p> CONCLUSION: Nipple fluid CEAs are higher for breasts with untreated invasive cancers, but the test sensitivity is low. Nipple fluid PSA titers do not seem to be useful for breast cancer detection. <\/jats:p>","DOI":"10.1200\/jco.2001.19.5.1462","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T08:08:14Z","timestamp":1487923694000},"page":"1462-1467","source":"Crossref","is-referenced-by-count":41,"title":["Nipple Fluid Carcinoembryonic Antigen and Prostate-Specific Antigen in Cancer-Bearing and  Tumor-Free Breasts"],"prefix":"10.1200","volume":"19","author":[{"given":"Yashuang","family":"Zhao","sequence":"first","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigitas J.","family":"Verselis","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Klar","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman L.","family":"Sadowsky","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M.","family":"Kaelin","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Smith","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Foretova","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick P.","family":"Li","sequence":"additional","affiliation":[{"name":"From the Department of Adult Oncology, Population Sciences, and the Department of Biostatistics, Dana-Farber Cancer Institute; Brigham & Women\u2019s Hospital; Massachusetts General Hospital, Boston; and Faulkner Hospital, Jamaica Plain, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-35453","unstructured":"Forbes  JF:   The incidence of breast cancer:   The global burden, public health considerations.   Semin Oncol 24:  S1-20,1997-S1-35,"},{"key":"R2-35453","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P"},{"key":"R4-35453","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07413-3"},{"key":"R5-35453","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704173361612"},{"key":"R6-35453","doi-asserted-by":"crossref","unstructured":"Kerlikowske  K:   Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years:   Comparison of relative and absolute benefit.   J Natl Cancer Inst Monogr 22:  79,1997-86,","DOI":"10.1093\/jncimono\/1997.22.79"},{"key":"R7-35453","doi-asserted-by":"crossref","unstructured":"Hendrick  RE,   Smith  RA,   Rutledge  JH, III,  et al:  Benefit of screening mammography in women aged 40-49:   A new meta-analysis of randomized controlled trials.   J Natl Cancer Inst Monogr 22:  87,1997-92,","DOI":"10.1093\/jncimono\/1997.22.87"},{"key":"R8-35453","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.415"},{"key":"R9-35453","unstructured":"Petrakis  NL:   Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid.   Cancer Epidemiol Biomarkers Prev 2:  3,1993-10,"},{"key":"R10-35453","unstructured":"Foretova  L,   Garber  J,   Sadowsky  N,  et al:  Carcinoembryonic antigen in breast nipple aspirate fluid.   Cancer Epidemiol Biomarkers Prev 7:  195,1998-198,"},{"key":"R11-35453","doi-asserted-by":"publisher","DOI":"10.1084\/jem.121.3.439"},{"key":"R12-35453","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.682"},{"key":"R13-35453","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058385"},{"key":"R14-35453","unstructured":"Ebeling  FC,   Schmitt  UM,   Untch  M,  et al:  Tumour markers CEA and CA 15-3 as prognostic factors in breast cancer:   Univariate and multivariate analysis.   Anticancer Res 19:  2545,1999-550,"},{"key":"R15-35453","doi-asserted-by":"crossref","unstructured":"Foretova  L,   Garber  JE,   Sadowsky  NL,  et al:  Prostate-specific antigen in nipple aspirate.   Lancet 347:  1631,1996  (letter)","DOI":"10.1016\/S0140-6736(96)91120-4"},{"key":"R16-35453","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.401"},{"key":"R17-35453","unstructured":"Sauter  E,   Daly  M,   Linahan  K,  et al:  Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.   Cancer Epidemiol Biomarkers Prev 5:  967,1996-970,"},{"key":"R20-35453","doi-asserted-by":"crossref","unstructured":"Papanicolaou  GN,   Holmquist  DG,   Bader  GM,  et al:  Exfoliate cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast.   Cancer 2:  377,1958-409,","DOI":"10.1002\/1097-0142(195803\/04)11:2<377::AID-CNCR2820110223>3.0.CO;2-A"},{"key":"R21-35453","doi-asserted-by":"publisher","DOI":"10.1007\/BF01805919"},{"key":"R22-35453","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116266"},{"key":"R23-35453","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806336"},{"key":"R24-35453","doi-asserted-by":"publisher","DOI":"10.1007\/BF01811888"},{"key":"R25-35453","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910400502"},{"key":"R26-35453","unstructured":"Gruenke  LD,   Wrensch  MR,   Petrakis  NL,  et al:  Breast fluid cholesterol and cholesterol epoxides:   Relationship to breast cancer risk factors and other characteristics.   Cancer Res 47:  5483,1987-5487,"},{"key":"R27-35453","unstructured":"Ernster  VL,   Wrensch  MR,   Petrakis  NL,  et al:  Benign and malignant breast disease:   Initial study results of serum and breast fluid analyses of endogenous estrogens.   J Natl Cancer Inst 79:  949,1987-960,"},{"key":"R28-35453","unstructured":"Vollmer  RT,   Montana  GS:   The dynamics of prostate-specific antigen after definitive radiation therapy for prostate cancer.   Clin Cancer Res 5:  4119,1999-4125,"},{"key":"R29-35453","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.12.1033"},{"key":"R32-35453","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jjco.a039328"},{"key":"R33-35453","unstructured":"Mori  T,   Inaji  H,   Koyama  H,  et al:  Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer:   Results of a multicenter study.   Jpn J Clin Oncol 22:  371,1992-376,"},{"key":"R34-35453","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871215)60:12<3008::AID-CNCR2820601225>3.0.CO;2-L"},{"key":"R35-35453","unstructured":"Ito  Y,   Tamaki  Y,   Nakano  Y,  et al:  Nonpalpable breast cancer with nipple discharge:   How should it be treated?   Anticancer Res 17:  791,1997-794,"},{"key":"R36-35453","unstructured":"Yayoi  E,   Furukawa  J,   Sekimoto  M,  et al:  Early detection of non-palpable (TO) breast cancer:   The diagnostic procedure for pathological discharge from the nipple.   Jpn J Cancer Chemother 2:  133,1994-139,"},{"key":"R37-35453","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690832"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2001.19.5.1462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:47:41Z","timestamp":1653515261000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2001.19.5.1462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["10.1200\/JCO.2001.19.5.1462"],"URL":"https:\/\/doi.org\/10.1200\/jco.2001.19.5.1462","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]}}}